13 results - M - W - D

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

#f

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/16/25 18:27
9/4/25
BBIOHealthDrugPharmaceutical PreparationsKumar NeilCADOCEO17S.dm-67,20442.670-1,5756,906I
12/10/25 07:53
12/8/25
BBIOHealthDrugPharmaceutical PreparationsApuli MaricelCAOChief Ac3S-23357.990-4148D
11/19/25 17:08
11/17/25
BBIOHealthDrugPharmaceutical PreparationsLo AndrewCAD2S.m-10,17051.990-196154M
11/19/25 17:06
11/17/25
BBIOHealthDrugPharmaceutical PreparationsScott Randal W.CAD1S.d-66666.650-1016D
11/18/25 19:28
11/17/25
BBIOHealthDrugPharmaceutical PreparationsTrimarchi ThomasCAOP,CFO3S-4,08753.410-77463D
11/14/25 16:50
11/12/25
BBIOHealthDrugPharmaceutical PreparationsValantine HannahCAD4S.d-2,48252.410-478D
11/7/25 18:03
11/6/25
BBIOHealthDrugPharmaceutical PreparationsDaniels Ronald JCAD1S.d-3,88963.720-6117D
10/31/25 16:38
10/29/25
BBIOHealthDrugPharmaceutical PreparationsMcCormick FrankCAD4S.d-21,67057.940-374963I
8/12/25 19:06
8/8/25
BBIOHealthDrugPharmaceutical PreparationsHomcy Charles JCAD1S.m-13,91246.370-300917D
8/7/25 16:50
8/5/25
BBIOHealthDrugPharmaceutical PreparationsEllis AndreaCAD3S.d-2,21338.710-5719D
7/1/25 19:48
6/27/25
BBIOHealthDrugPharmaceutical PreparationsViking Global Investors LPCTT2S-260,99039.750-6,56622,055I
5/14/25 17:24
5/12/25
BBIOFinancInvAdvInvestment AdviceKkr Genetic Disorder L.P.NYT3S-552,31031.030-17,80025,261I
2/27/25 17:36
2/25/25
BBIOHealthDrugPharmaceutical PreparationsStephenson Brian CCAOCFO,Trea5S.d-3,09634.800-89102D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact